Shock Wave Therapy for Sural Myofascial Pain Associated to Chronic Heel Pain
CompletedNot applicableNCT04385329
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this randomized controlled study in to investigate if a shock wave treatment extended to the gastrocnemius-soleus trigger points (TrP) is more effective than a standard treatment exclusively targeted at the plantar fascia in a population affected by unilateral plantar fasciitis with concomitant sural myofascial pain syndrome.
Study details
- Official title
- Shock Wave Therapy for Sural Myofascial Pain Syndrome Associated With Plantar Fasciitis: a Pilot Randomized Controlled Trial
- Conditions
- Tendinopathy
- Interventions
- Other: Shock wave therapy on plantar fascia extended to the gastrocnemius-soleus trigger points
- Other: Shock wave therapy on plantar fascia only
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Start date
- 2016-07-04
- Primary completion
- 2018-07-04
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adult age (18 to 75 years) and written informed consent; * Unilateral heel pain of four weeks or longer duration; * Pain to digital pressure in the insertional area of the plantar fascia at the calcaneum; * Sonographic examination showing a plantar fascia thickness greater than 3.8mm (see procedures for details); * Concomitant presence of a sural myofascial pain syndrome (SMPS), diagnosed on the basis of the finding, at the physical examination, of trigger points of the gastrocnemius-soleus muscle complex, according to Travel and Simons' original description. Exclusion Criteria: * No corticosteroid injections or other physical therapies since the onset of the current pain episode (except pharmacological pain treatments and foot orthoses); * No general contraindication to shock wave therapy (pregnancy, bleeding disorders or anticoagulant drug usage, cancer in the focal area); * No clinical signs of lumbar radiculopathy at physical examination; * No ankle osteoarthritis, diagnosed on the basis of clinical and radiographic findings; * No previous fractures or surgery in the affected ankle and foot; * No rheumatologic diseases, no plantar fibromatosis
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04385329